What is it about?
This paper delineates different estimands of a comparative clinical trial
Featured Image
Why is it important?
An "estimand" is "what question the analysis aims to address", hence it is the foremost important subject for a clinical trial.
Perspectives
This commentary on the FDA's papers further clarifies the issue of estimands and sensitivity analysis.
Weichung Shih
Read the Original
This page is a summary of: Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem, Statistics in Medicine, July 2016, Wiley,
DOI: 10.1002/sim.6895.
You can read the full text:
Contributors
The following have contributed to this page







